Increased risk for microvascular complications among women with gestational diabetes in the third trimester.


Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 25 05 2021
revised: 17 08 2021
accepted: 20 09 2021
pubmed: 27 9 2021
medline: 25 11 2021
entrez: 26 9 2021
Statut: ppublish

Résumé

The risk of microvascular disease has been thought to commence with the onset of overt diabetes. Women with gestational diabetes have only had a short-term exposure to frank hyperglycemia, but, due to underlying β-cell dysfunction, they may also have had long-term exposure to mild degrees of hyperglycemia. The aim of the study was to determine whether women with gestational diabetes are at increased risk for microalbuminuria and retinopathy compared to women with normal glucose tolerance in pregnancy. We recruited women aged ≥ 25 years with singleton pregnancies at 32 to 40 weeks' gestational age, with and without gestational diabetes. Women with hypertension, preeclampsia, or pre-gestational diabetes were excluded. Of 372 women included in the study, 195 had gestational diabetes. The prevalence of microalbuminuria was 15% among those with gestational diabetes versus 6% in those with normal glucose tolerance (adjusted odds ratio 2.4, 95% confidence interval 1.1 to 5.2, p = 0.006). Diastolic blood pressure and HbA1c were associated with microalbuminuria. The prevalence of retinopathy did not differ between groups (10% versus 11%). Women with gestational diabetes have an increased risk of microalbuminuria in the third trimester, despite having been exposed to only a brief period of overt hyperglycemia.

Identifiants

pubmed: 34563584
pii: S0168-8227(21)00427-7
doi: 10.1016/j.diabres.2021.109068
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109068

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Baiju R Shah (BR)

Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Sunnybrook Research Institute, Toronto, ON, Canada; Department of Medicine, University of Toronto, ON, Canada. Electronic address: baiju.shah@ices.on.ca.

Denice S Feig (DS)

Department of Medicine, University of Toronto, ON, Canada; Mount Sinai Hospital, Toronto, ON, Canada.

Elaine Herer (E)

Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Obstetrics and Gynaecology, University of Toronto, ON, Canada.

Michelle A Hladunewich (MA)

Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Sunnybrook Research Institute, Toronto, ON, Canada; Department of Medicine, University of Toronto, ON, Canada.

Alexander Kiss (A)

Sunnybrook Research Institute, Toronto, ON, Canada.

Radha P Kohly (RP)

Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Ophthalmology and Vision Sciences, University of Toronto, ON, Canada.

Lorraine L Lipscombe (LL)

Department of Medicine, University of Toronto, ON, Canada; Women's College Hospital, Toronto, ON, Canada.

Paul M Yip (PM)

Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada.

David Z Cherney (DZ)

Department of Medicine, University of Toronto, ON, Canada; University Health Network, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH